Quality Control Testing

Quality Control Testing
Product Description

Analytical chemistry services from SGS provide you with the bio/pharmaceutical expertise and regulatory qualifications to perform the necessary raw material testing, and testing on APIs, finished products, packaging material and medical devices.

SGS North America Inc.

  • Country/Region:
    United States
  • On CPHI since:
    2015

SGS North America Inc.

  • Country/Region:
    United States
  • On CPHI since:
    2015

More Products from SGS North America Inc. (2)

  • Biologics Characterization Services

    Product Biologics Characterization Services

    As a pioneer of physicochemical characterization, we offer you unrivaled expertise in protein analysis. Our laboratories helped to develop mass spectrometry (MS) mapping of biotechnology products, together with other mass spectrometry strategies related to protein/glycoprotein analysis, which have become s...
  • Extractables & Leachables Testing

    Product Extractables & Leachables Testing

    The assessment of Extractables and Leachables in bio/pharmaceutical products is an important step in drug product development. Processing equipment, as well as, primary and secondary container closures are potential vectors for chemical contaminants. Monomers and polymer additives such as antioxidants, pla...

SGS North America Inc. resources (2)

  • Brochure Bioanalysis Testing Solutions

    With over 30 years of experience and operating out of our GLP/GCP compliant laboratories. SGS has the expertise to both develop assays from scratch (including LC-MS/MS, immunoassays and cell-based assays) and to support large scale routine sample analyses, from regulatory pre-clinical (toxicology) to early and late clinical studies (Phase I to IV).

  • Video Multi-Attribute Method: An Emerging Platform for Product Development

    A review of various methods and instrumentation, including the benefits and limitations for each in biomanufacturing. Regulatory views, including description of use/acceptance at each phase of drug discovery from pre-clinical through BLA. Case Study.